The international carrier Qatar Airways is facing a legal storm after a reported in‑flight allergy incident involving a child passenger. According to a lawsuit filed in a US court, a three‑year‑old girl suffered a severe allergic reaction after being given a chocolate snack aboard Flight QR 710 from Washington Dulles (IAD) to Doha (DOH).
Incident overview
The suit, lodged in Virginia, claims the girl’s mother had clearly informed the airline—both in advance and in person at boarding—that her daughter had severe allergies to dairy and nuts. Nevertheless, during the flight the child was allegedly offered a chocolate bar (identified as a KitKat) by a flight attendant during a brief moment when the mother stepped away.
The complaint states that when the mother returned, she found her daughter eating the snack and that the attendant had admitted giving it despite the warnings. The incident escalated quickly. The toddler’s condition deteriorated in mid‐air and required administration of an EpiPen (epinephrine) to stabilise her.
Legal claims and arguments
The lawsuit argues that by offering a snack known to contain potential allergens and dismissing the mother’s concerns—the airline breached its duty of care. It points to the fact that the carrier had been made aware of the allergies, triggering a heightened responsibility to prevent exposure.
Further, the case invokes the Montreal Convention, which governs international air carriers’ liability for injuries suffered during a flight. Although the convention typically limits compensation to roughly US $170,000 in many cases, the filing seeks US $5 million in damages for “full, fair and reasonable” relief given the alleged physical and emotional harm.
Airline response and broader implications
At the time of writing, Qatar Airways had not publicly provided a full statement beyond acknowledging the incident and that it is reviewing the matter. The case underscores broader concerns over how airlines handle passengers with life‑threatening allergies, especially on long‑haul international flights.
In the United States, for instance, the Federal Aviation Administration (FAA) does not mandate that airlines carry EpiPens specifically; many are required only to carry epinephrine vials that must be administered by a medical professional. The case raises questions about crew training, in‑flight snack protocols, and emergency readiness in allergy situations.
What happened after the flight
According to the complaint, the young girl suffered another allergic reaction during a connecting flight to India and required intensive care. This after‑shock serves to heighten the seriousness of the airline’s alleged failure to act appropriately during the first incident.
Why this matters
For airlines, this case illuminates a number of pressing issues:
- The need for clear policies when passengers disclose severe food allergies.
- The importance of training cabin crews to recognise allergy risks and to follow strict snack/allergen protocols.
- The potential legal and reputational risks when things go wrong.
- The broader passenger expectation that international carriers have robust health‑ and allergy‑safety measures in place, especially on flights that may cross time zones and involve long durations.
For travellers, especially those with known food allergies, the suit is a reminder to:
- Provide detailed allergy information in advance and again at boarding.
- Confirm with the carrier what snacks will be distributed onboard, especially if the flight offers complimentary catering.
- Carry necessary emergency medication (like epinephrine) and ensure travel companions and crew are aware of your condition.
- Be aware of the airline’s medical and allergy policies—some carriers offer allergen‑free meals or special seating arrangements.
Looking ahead
As the legal proceedings move forward, observers will watch how Qatar Airways defends its service protocols, crew training and emergency handling procedures. The case may prompt broader industry reviews of allergy risk management on commercial flights, and whether current regulatory frameworks are sufficient for long‑haul, international passenger safety.
Should the plaintiff succeed in securing the US $5 million claim, this case could become a landmark for how airlines manage food‑allergy incidents. Equally, the carrier may seek to settle to avoid protracted litigation and reputational damage.
In the meantime, passengers and airlines alike will be paying closer attention to how allergies are handled at 35,000 feet.
Do Follow Gulf Magazine on Instagram
Read More:- Global Acai Berry Market Set for Explosive USD 3.6 Billion Growth by 2035
